Assignee
CASTLE BIOSCIENCES INC
US·5 granted patents·10 pending applications·2 citations·filing 2014–2025
Top patents by PatentIndex Score
15 records- 0181US10577660B2Diagnostic test for predicting metastasis and recurrence in cutaneous melanomaCASTLE BIOSCIENCES INC·Filed 2016·Granted Mar 3, 2020·2 cites·12 claims
- 0281US2026015676A1Diagnostic test for predicting metastasis and recurrence in cutaneous melanomaCASTLE BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 0379US2025305065A1Diagnostic test for predicting metastasis and recurrence in cutaneous melanomaCASTLE BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 0476US12365948B2Diagnostic test for predicting metastasis and recurrence in cutaneous melanomaCASTLE BIOSCIENCES INC·Filed 2022·Granted Jul 22, 2025·0 cites·7 claims
- 0571US2025019767A1Methods of diagnosing and treating patients with cutaneous squamous cell carcinomaCASTLE BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 0666US11434536B2Diagnostic test for predicting metastasis and recurrence in cutaneous melanomaCASTLE BIOSCIENCES INC·Filed 2020·Granted Sep 6, 2022·0 cites·7 claims
- 0766US2014271545A1Methods for predicting risk of metastasis in cutaneous melanomaCASTLE BIOSCIENCES INC·Filed 2014·Application pending·0 cites
- 0866US2025019768A1Methods of diagnosing and treating patients with cutaneous squamous cell carcinomaCASTLE BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 0966US2014272986A1Diagnostic test for predicting metastasis and recurrence in cutaneous melanomaCASTLE BIOSCIENCES INC·Filed 2014·Application pending·0 cites
- 1057US11976331B2Methods of diagnosing and treating patients with cutaneous squamous cell carcinomaCASTLE BIOSCIENCES INC·Filed 2020·Granted May 7, 2024·0 cites·14 claims
- 1156US2025215507A1Methods of diagnosing and treating patients with cutaneous squamous cell carcinomaCASTLE BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 1253US2022033882A1Methods of diagnosing and treating patients with pigmented skin lesionsCASTLE BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 1352US11976333B2Methods of diagnosing and treating patients with cutaneous squamous cell carcinomaCASTLE BIOSCIENCES INC·Filed 2020·Granted May 7, 2024·0 cites·17 claims
- 1450US2022285032A1Determining Prognosis and Treatment based on Clinical-Pathologic Factors and Continuous Multigene-Expression Profile ScoresCASTLE BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1543US2025243552A1Methods of diagnosing and treating patients with cutaneous squamous cell carcinomaCASTLE BIOSCIENCES INC·Filed 2025·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →